Related Experiment Video
Updated: Aug 6, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
Predictors of cerebral microbleeds in acute ischemic stroke and TIA patients
Bruce Ovbiagele1, Jeffrey L Saver, Nerses Sanossian
1UCLA Stroke Center, UCLA Medical Center, Los Angeles, Ca 90095, USA. Ovibes@mednet.ucla.edu
Background:
Cerebral microbleeds (CMB) detected on gradient-echo T2*-weighted MRI have been associated with cognitive impairment and the potential for increased risk of intracranial hemorrhage. We evaluated risk factors for these microangiopathic lesions in a cohort of stroke and transient ischemic attack patients.
Methods:
Presence and number of CMB in consecutive acute stroke patients admitted to a university hospital stroke service over an 18-month period were rated. Multivariate models were generated to determine the contribution of 21 demographic and clinical variables to the frequency and number of CMB.
Results:
Of 164 patients (mean age 71 years, 52% female), 57 (35%) had CMB evident on gradient-echo T2*-weighted MRI. CMB were more commonly noted among patients with small vessel disease ischemic stroke mechanism (47%) than large vessel atherothromboembolic (12%) or cardioembolic (18%, p = 0.0001). In univariate analysis, patients with CMB were older, (p = 0.008), more likely to have been on >1 antihypertensive prior to admission (p = 0.024) than those without CMB. In multivariate logistic regression analyses, presumed small vessel stroke subtype, history of atrial fibrillation, being on >1 antihypertensive prior to admission, and smoking were independent factors increasing the risk of CMB. Logistic regression analysis by number of CMB showed almost similar findings.
Conclusions:
CMB are more frequently noted in hospitalized stroke and transient ischemic attack patients with small vessel ischemia, as well as those with important modifiable vascular risk factors like atrial fibrillation and smoking.
Insights
Cerebral microbleeds (CMB) are linked to small vessel disease and modifiable risks like atrial fibrillation and smoking in stroke patients. Identifying these factors can help manage risks and prevent future cerebrovascular events.
Area of Science:
- Neurology
- Radiology
- Vascular Medicine
Background:
- Cerebral microbleeds (CMB) on MRI are associated with cognitive decline and hemorrhage risk.
- Understanding risk factors for CMB is crucial in stroke and TIA patients.
Purpose of the Study:
- To identify demographic and clinical risk factors for cerebral microbleeds in stroke patients.
- To evaluate the contribution of various factors to the frequency and number of CMB.
Main Methods:
- Retrospective analysis of 164 acute stroke patients over 18 months.
- Gradient-echo T2*-weighted MRI used to detect CMB.
- Multivariate logistic regression models applied to 21 variables.
Main Results:
- 35% of patients had detectable CMB.
- CMB more frequent in small vessel disease stroke (47%) vs. other types (p=0.0001).
- Independent risk factors for CMB included small vessel stroke, atrial fibrillation, multiple antihypertensives, and smoking.
Conclusions:
- CMB are prevalent in hospitalized stroke/TIA patients with small vessel ischemia.
- Modifiable vascular risk factors like atrial fibrillation and smoking increase CMB risk.
- Findings highlight targets for CMB risk reduction in cerebrovascular disease.
Related Concept Videos
Transient Ischemic Attack l: Introduction
Ischemic Stroke l: Introduction
Hemorrhagic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology